Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.

MLA

Sasanejad, Payam, et al. “Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, vol. 30, no. 12, Dec. 2021, p. 106121. EBSCOhost, https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106121.

APA

Sasanejad, P., Afshar Hezarkhani, L., Arsang-Jang, S., Tsivgoulis, G., Ghoreishi, A., Barlinn, K., Rahmig, J., Farhoudi, M., Sadeghi Hokmabadi, E., Borhani-Haghighi, A., Sariaslani, P., Sharifi-Razavi, A., Ghandehari, K., Khosravi, A., Smith, C., Nilanont, Y., Akbari, Y., Nguyen, T. N., Bersano, A., … Azarpazhooh, M. R. (2021). Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative. Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, 30(12), 106121. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106121

Chicago

Sasanejad, Payam, Leila Afshar Hezarkhani, Shahram Arsang-Jang, Georgios Tsivgoulis, Abdoreza Ghoreishi, Kristian Barlinn, Jan Rahmig, et al. 2021. “Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association 30 (12): 106121. doi:10.1016/j.jstrokecerebrovasdis.2021.106121.